Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study

Lung

Volumn 193, Issue 6, 2015, Pages 993-1000

  Alemán, Carmen ^a   Porcel, José M ^b   Alegre, José ^a   Ruiz, Eva ^a   Bielsa, Silvia ^b   Andreu, Jordi ^a   Deu, Maria ^a   Suñé, Pilar ^a   Martínez Sogués, Mireia ^b   López, Iker ^a   Pallisa, Esther ^a   Schoenenberger, Joan Antoni ^b   Bruno Montoro, J ^a   de Sevilla, Tomás Fernández ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Empyema; Fibrinolytic therapy; Parapneumonic pleural effusion

Indexed keywords

ALTEPLASE; AMOXICILLIN PLUS CLAVULANIC ACID; GLUCOSE; LACTATE DEHYDROGENASE; UROKINASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COMPLICATED PARAPNEUMONIC EFFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FIBRINOLYTIC THERAPY; HEMATOTHORAX; HEMOPTYSIS; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT REFERRAL; PH; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL DRAINAGE; THORAX RADIOGRAPHY; TREATMENT DURATION; AGED; CHEST TUBE; COMPARATIVE STUDY; EMPYEMA, PLEURAL; PLEURAL EFFUSION; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; CHEST TUBES; DOUBLE-BLIND METHOD; EMPYEMA, PLEURAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84947491550     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9807-6     Document Type: Article

References (23)

1. Bryant R, Salmon C (1996) Pleural empyema. Clin Infect Dis 22:747–764
2. Kroegel C, Antony VB (1997) Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 10:2411–2418
3. Segura RM, Alegre J, Varela E et al (1998) Interleukin-8 and markers of neutrophil degranulation in pleural effusion. Am J Respir Crit Care Med 157:1565–1572
4. Idell S, Zwieb C, Kumar A, Koenig K, Johnson A (1992) Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 7:414–426
5. Hua CC, Chang LC, Chen YC, Chang SC (1999) Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 116:1292–1296
6. Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC (2005) Proinflammatory cytokines, transforming growth factor-beta1 and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 128:690–697
7. Idell S, Girard W, Koenig K, McLarty J, Fair D (1991) Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 144:187–194
8. Philip-Joët F, Alessi MC, Philip Joët C et al (1995) Fibrinolytic and inflammatory processes in pleural effusions. Eur Resp J 8:1352–1356
9. Alemán C, Alegre J, Monasterio J et al (2003) Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) 105:601–607
10. Davies RJ, Traill ZC, Gleeson FV (1997) Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 52:416–421
11. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N (1999) Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 159:37–42
12. Tuncozgur B, Ustunsoy H, Sivrikoz MC et al (2001) Intrapleural urokinase in the management of parapneumonic empyema: a randomized controlled trial. Int J Clin Pract 55:658–660
13. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT (2004) Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 170:49–53
14. Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A (2005) Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg 28:599–603
15. Maskell NA, Davies CW, Nunn AJ, First Multicenter Intrapleural Sepsis Trial (MIST1) Group et al (2005) UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865–874
16. Rahman NM, Maskell NA, West A et al (2011) Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 365:518–526
17. Janda S, Swiston J (2012) Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas. Chest 142:401–411
18. Nie W, Liu Y, Ye J, Shi L, Shao F, Ying K, Zhang R (2014) Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusions: a meta-analysis of randomized control trials. Clin Respir J. 8:281–291
19. Schmulling S, Grond M, Rudolf J, Heiss WD (2000) One-year follow-up in acute stroke patients treated with r-TPA in clinical routine. Stroke 31:1552–1554
20. Morelloni S, Fasciolo L, Freggiaro V et al (1990) A comparative evaluation between streptokinase and r-TPA in limiting the myocardial damage during an acute myocardial infarct. An echocardiographic study. Clin Ter 135:359–365
21. Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT (2012) A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med 106:716–723
22. Weinstein M, Restrepo R, Chait PG, Connoly B, Temple M, Mcarthur C (2004) Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics 113:e182–e185
23. Goralski JL, Bromberg PA (2009) Intrapleural hemorrhage after administration of tPA: a case report and review of the literature. Ther Adv Respir Dis 3:295–300